Liquid chromatography-tandem mass spectrometry for the simultaneous quantitation of ceftriaxone, metronidazole and hydroxymetronidazole in plasma from seriously ill, severely malnourished children
Martin Ongas, Joseph Standing, Bernhards Ogutu, Joseph Waichungo, James A Berkley, Karin Kipper, Martin Ongas, Joseph Standing, Bernhards Ogutu, Joseph Waichungo, James A Berkley, Karin Kipper
Abstract
We have developed and validated a novel, sensitive, selective and reproducible reversed-phase high-performance liquid chromatography method coupled with electrospray ionization mass spectrometry (HPLC-ESI-MS/MS) for the simultaneous quantitation of ceftriaxone (CEF), metronidazole (MET) and hydroxymetronidazole (MET-OH) from only 50 µL of human plasma, and unbound CEF from 25 µL plasma ultra-filtrate to evaluate the effect of protein binding. Cefuroxime axetil (CEFU) was used as an internal standard (IS). The analytes were extracted by a protein precipitation procedure with acetonitrile and separated on a reversed-phase Polaris 5 C18-Analytical column using a mobile phase composed of acetonitrile containing 0.1% (v/v) formic acid and 10 mM aqueous ammonium formate pH 2.5, delivered at a flow-rate of 300 µL/min. Multiple reaction monitoring was performed in the positive ion mode using the transitions m/z555.1→ m/z396.0 (CEF), m/z172.2→ m/z 128.2 (MET), m/z188.0→ m/z125.9 (MET-OH) and m/z528.1→ m/z 364.0 (CEFU) to quantify the drugs. Calibration curves in spiked plasma and ultra-filtrate were linear ( r 2 ≥ 0.9948) from 0.4-300 µg/mL for CEF, 0.05-50 µg/mL for MET and 0.02 - 30 µg/mL for MET-OH. The intra- and inter- assay precisions were less than 9% and the mean extraction recoveries were 94.0% (CEF), 98.2% (MET), 99.6% (MET-OH) and 104.6% (CEF in ultra-filtrate); the recoveries for the IS were 93.8% (in plasma) and 97.6% (in ultra-filtrate). The validated method was successfully applied to a pharmacokinetic study of CEF, MET and MET-OH in hospitalized children with complicated severe acute malnutrition following an oral administration of MET and intravenous administration of CEF over the course of 72 hours.
Keywords: LC-MS/MS; ceftriaxone; complicated severe acute malnutrition; metronidazole; protein binding; ultrafiltration.
Conflict of interest statement
Competing interests: No competing interests were disclosed. No writing assistance was utilized in the production of this manuscript.
Figures
References
- Maitland K, Berkley JA, Shebbe M, et al. : Children with Severe Malnutrition: can Those at Highest Risk of Death Be Identified with the WHO Protocol? PLoS Med. 2006;3(12):e500. 10.1371/journal.pmed.0030500
- Vincent JL, Rello J, Marshall J, et al. : International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–9. 10.1001/jama.2009.1754
- Tickell KD, Denno DM: Inpatient management of children with severe acute malnutrition: a review of WHO guidelines. Bull World Health Organ. 2016;94(9):642–51. 10.2471/BLT.15.162867
- Berkley JA, Ngari M, Thitiri J, et al. : Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial. Lancet Glob Health. 2016;4(7):464–73. 10.1016/S2214-109X(16)30096-1
- Kollef MH, Sherman G, Ward S, et al. : Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462–74. 10.1378/chest.115.2.462
- Garnacho-Montero J, Garcia-Garmendia J, Barrero-Almodovar A, et al. : Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31(12):2742–51. 10.1097/01.CCM.0000098031.24329.10
- Harbarth S, Garbino J, Pugin J, et al. : Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med. 2003;115(7):529–35. 10.1016/j.amjmed.2003.07.005
- Lazzerini M, Tickell D: Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics. Bull World Health Organ. 2011;89(8):594–607. 10.2471/BLT.10.084715
- Williams P, Berkley J: Severe acute malnutrition update: current WHO guidelines and the WHO essential medicine list for children.2016.
- Easmon CS, Ison CA, Kaye CM, et al. : Pharmacokinetics of metronidazole and its principal metabolites and their activity against Gardnerella vaginalis. Br J Vener Dis. 1982;58(4):246–9. 10.1136/sti.58.4.246
- O'Keefe JP, Troc KA, Thompson KD: Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria. Antimicrob Agents Chemother. 1982;22(3):426–30. 10.1128/AAC.22.3.426
- Silva M, Schramm S, Kano E, et al. : Development and validation of a HPLC-MS-MS method for quantification of metronidazole in human plasma. J Chromatogr Sci. 2009;47(9):781–4. 10.1093/chromsci/47.9.781
- Ezzeldin E, El-Nahhas T: New Analytical Method for the Determination of Metronidazole in Human Plasma: Application to Bioequivalence Study. Tropical Journal of Pharmaceutical Research. 2012;11(5):799–805. 10.4314/tjpr.v11i5.14
- Kurji HA, Ghareeb MM, Zalzala MH, et al. : Serum Level Profile and Pharmacokinetic Parameters of Single Oral Dose of Metronidazole in Type II Diabetic Patients. Iraqi J Pharm Sci. 2011;20(1):14–8.
- Ilomuanya M, Uboh C, Ciallella J, et al. : Analysis of metronidazole in equine plasma using liquid chromatography/tandem mass spectrometry and high-resolution accurate mass spectrometry. Rapid Commun Mass Spectrom. 2015;29(8):753–63. 10.1002/rcm.7158
- Houghton GW, Hundt HK, Muller FO, et al. : A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole. Br J Clin Pharmacol. 1982;14(2):201–6. 10.1111/j.1365-2125.1982.tb01962.x
- Wong G, Briscoe S, Adnan S, et al. : Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations? Antimicrob Agents Chemother. 2013;57(12):6165–70. 10.1128/AAC.00951-13
- Schleibinger M, Steinbach CL, Töpper C, et al. : Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients. Br J Clin Pharmacol. 2015;80(3):525–33. 10.1111/bcp.12636
- Heuberger J, Schmidt S, Derendorf H: When is protein binding important? J Pharm Sci. 2013;102(9):3458–67. 10.1002/jps.23559
- De Cock RD, Smits A, Allegaert K, et al. : Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates. J Antimicrob Chemother. 2014;69(5):1330–8. 10.1093/jac/dkt527
- Blot SI, Pea F, Lipman J: The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev. 2014;77:3–11. 10.1016/j.addr.2014.07.006
- Berezhkovskiy LM: On the temperature dependence of the unbound drug fraction in plasma: Ultrafiltration method may considerably underestimate the true value for highly bound drugs. Drug Discov Ther. 2008;2(2):74–6.
- Joynt GM, Lipman J, Gomersall CD, et al. : The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients. J Antimicrob Chemother. 2001;47(4):421–9. 10.1093/jac/47.4.421
- Zhang J, Musson DG: Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;843(1):47–56. 10.1016/j.jchromb.2006.05.042
- van Liempd S, Morrison D, Sysmans L, et al. : Development and validation of a higher-throughput equilibrium dialysis assay for plasma protein binding. J Lab Autom. 2011;16(1):56–67. 10.1016/j.jala.2010.06.002
- Sultana N, Arayne M, Shahzad W: Simultaneous Determination of Ceftriaxone Sodium and Non Steroidal Anti-Inflammatory Drugs in Pharmaceutical Formulations and Human Serum by RP-HPLC. J Chin Chem Soc-Taip. 2010;57(6):1278–85. 10.1002/jccs.201000189
- Sun H, Wang H, Ge X, et al. : Simultaneous Determination of the combined drugs Ribavirin and Ceftriaxone sodium in human urine by HPLC-DAD. Int Journal of Sc Innovations and Disc. 2011;1(2):216–25.
- Sun H, Wang H, Ge X: Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography. J Clin Lab Anal. 2012;26(6):486–92. 10.1002/jcla.21551
- Sar T, Mandal T, Das S, et al. : Pharmacokinetics of Ceftriaxone in Healthy and Mastitic Goats With Special Reference to Its Interaction. With Polyherbal Drug (Fibrosin®). Intern J Appl Res Vet Med. 2006;4(2):142–54.
- Administration UDoHaHSFaD: Guidance for Industry: Bioanalytical method validation.2013.
- European Medicines Agency: Guideline on Validation of Bioanalytical Methods.2011.
- Deshpand A, Baheti K, Chatterjee N: Degradation of Beta-lactam antibiotics. Current Science. 2004;87(12):1684–95.
- Frau J, Coll M, Donoso J, et al. : Alkaline and acidic hydrolysis of the beta-lactam ring. Electron J Theor Chem. 1997;2:56–65. 10.1002/ejtc.34
- Beale J, Jr, Block J: Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry.12th ed: Lippincott Williams & Wilkins;1998.
- Lemke T, Williams D: Foye's Principles of Medicinal Chemistry.6th ed.2008.
- Kruve A, Rebane R, Kipper K, et al. : Tutorial review on validation of liquid chromatography-mass spectrometry methods: part I. Anal Chim Acta. 2015;870:29–44. 10.1016/j.aca.2015.02.017
- Kruve A, Rebane R, Kipper K, et al. : Tutorial review on validation of liquid chromatography-mass spectrometry methods: part II. Anal Chim Acta. 2015;870:8–28. 10.1016/j.aca.2015.02.016
- Optimising Antibiotic Treatment for Sick Malnourished Children (FLACSAM-PK).2016.
Source: PubMed